A detailed history of Rowland & CO Investment Counsel transactions in Cryo Cell International Inc stock. As of the latest transaction made, Rowland & CO Investment Counsel holds 14,433 shares of CCEL stock, worth $91,793. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,433
Previous 14,433 -0.0%
Holding current value
$91,793
Previous $107,000 1.87%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 08, 2024

BUY
$4.86 - $8.04 $70,144 - $116,041
14,433 New
14,433 $107,000
Q1 2022

Apr 26, 2022

SELL
$7.28 - $11.84 $80,080 - $130,240
-11,000 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$11.27 - $13.9 $123,970 - $152,900
11,000 New
11,000 $0

Others Institutions Holding CCEL

About CRYO CELL INTERNATIONAL INC


  • Ticker CCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 8,519,250
  • Market Cap $54.2M
  • Description
  • Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative med...
More about CCEL
Track This Portfolio

Track Rowland & CO Investment Counsel Portfolio

Follow Rowland & CO Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rowland & CO Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Rowland & CO Investment Counsel with notifications on news.